Back to Search
LENA WOO, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1356180095Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Determination of the absolute configuration of aromatase and dual aromatase-sulfatase inhibitors by vibrational and electronic circular dichroism spectra analysis.
PMID 19161217·Chirality·2009
8-other
Catalytic reactions of carbene precursors on bulk gold metal.
PMID 19642683·J Am Chem Soc·2009
8-other
The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
PMID 19250195·Ann N Y Acad Sci·2009
6-review
Simulated childbirth injuries in an inbred rat strain.
PMID 18973147·Neurourol Urodyn·2009
7-preclinical
Results of a practical protocol for management of prenatally detected hydronephrosis due to ureteropelvic junction obstruction.
PMID 19043723·Pediatr Surg Int·2009
8-other
Prenatally detected ureteropelvic junction obstruction: clinical features and associated urologic abnormalities.
PMID 18256845·Pediatr Surg Int·2008
8-other
The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.
PMID 18450955·Endocrinology·2008
7-preclinical
A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
PMID 18927286·Clin Cancer Res·2008
7-preclinical
Cytokine expression after vaginal distention of different durations in virgin Sprague-Dawley rats.
PMID 18554634·J Urol·2008
7-preclinical
Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity.
PMID 18590272·J Med Chem·2008
8-other
Inhibition of steroid sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy.
PMID 19112542·ScientificWorldJournal·2008
8-other
Direct evidence for ArO-S bond cleavage upon inactivation of Pseudomonas aeruginosa arylsulfatase by aryl sulfamates.
PMID 18288656·Chembiochem·2008
8-other
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography.
PMID 18723489·Mol Cancer Ther·2008
7-preclinical
Non-steroidal aromatase inhibitors based on a biphenyl scaffold: synthesis, in vitro SAR, and molecular modelling.
PMID 18236493·ChemMedChem·2008
8-other
Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy.
PMID 18056119·Hum Reprod·2008
8-other
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
PMID 18816537·ChemMedChem·2008
8-other
Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.
PMID 17914670·Breast Cancer Res Treat·2008
7-preclinical
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
PMID 17728860·Org Biomol Chem·2007
8-other
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
PMID 17972413·Org Biomol Chem·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4500 PARSONS BLVD
FLUSHING, NY 11355 - Phone
- (718) 670-5000
Quick Facts
- NPI
- 1356180095
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile